Back to Authors

Khattab, Mohamed H.

https://orcid.org/0000-0002-9157-221X

Mayo Clinic

Vanderbilt University Medical Center

Citations 1

Radiotherapy and Radiosurgery for Treatment of Residual or Recurrent Endolymphatic Sac Tumor Following Previous Microsurgical Resection
Totten, Douglas J. , Manzoor, Nauman F. , Sherry, Alexander D. , Khattab, Mohamed H. , Link, Michael J. , Cmelak, Anthony J. , Haynes, David S. , Carlson, Matthew L. , Attia, Albert, Sherry, Alexander D , Rivas, Alejandro

Otology & Neurotology | April 9, 2020 | Volume: 41 | Issue: 6 | Pages: e759-e762

10.1097/mao.0000000000002639 Get It

Objective: To report and discuss the effectiveness of stereotactic radiosurgery (SRS) or fractionated radiotherapy (FRT) for tumor control following surgical resection of endolymphatic sac tumors (ELST). Study Design: Retrospective case series. Setting: Multi-institutional academic referral centers. Patients: Patients undergoing surgical resection for ELST followed by SRS or FRT. Intervention(s): Surgical resection followed by radiotherapy. Main Outcome Measures: Local tumor control. Results: Two of the five patients experienced tumor recurrence after gross total microsurgical at 78 and 11 months, respectively. The former patient received salvage 3D conformal radiotherapy (3D-CRT) and while the latter patient underwent three courses of salvage SRS for recurrence, two of which were in-field and was disease-free at last follow up. Two additional patients underwent subtotal tumor resection (STR) followed by intensity-modulated radiation therapy (IMRT) and are currently without disease. One patient underwent STR followed by proton-beam therapy (PBT) and was free of disease at most recent follow-up. Conclusion: SRS/FRT remains a useful adjuvant for treatment of residual or recurrent ELSTs, where the risk of revision microsurgical resection is high.